Effect of inhibitor concentration and end-product accumulation on estimates of ruminal in vitro protein degradation.
Effects of varying the concentrations of hydrazine sulfate (HS) and chloramphenicol (CAP), inhibitors of microbial-N uptake and protein synthesis, on rates of protein degradation estimated from net appearance of NH3 and total amino acids (TAA) were studied in a ruminal in vitro fermentation system. Without inhibitors, recoveries of N added as NH3 and TAA were 4 and 6% after 4-h incubations, and apparent degradation rates estimated from release of NH3 and TAA for casein, solvent soybean meal (SSBM), and expeller soybean meal (ESBM) approached 0. Increasing inhibitor concentrations from the standard amounts of 1 mM HS plus 30 mg of CAP/L to 2 mM HS plus 90 mg of CAP/ L gave rise to numerically greater N recoveries and degradation rates, but these differences were not statistically significant. Compared with the standard inhibitor concentrations, use of 2 mM HS, without CAP, yielded similar recoveries and rates, but 30 or 90 mg of CAP/L, without HS, was not satisfactory. Versus that with 1 mM HS plus 30 mg of CAP/L, media containing 2 mM HS plus 90 mg of CAP/L gave increased TAA recoveries and higher rates for casein, but not SSBM, in the presence of added starch. Faster degradation rates were obtained for casein, but slower rates for SSBM and ESBM, in Sweden versus Wisconsin using inocula from cows fed different diets but with similar CP and energy contents. Differences in microbial catabolism of peptides may account for differences in degradation rates observed between Sweden and Wisconsin. Adding NH3 plus free and peptide-bound amino acids to the inoculum reduced apparent degradation rates, possibly via end-product inhibition. Analysis of data from multiple time-point incubations indicated that casein degradation followed simple, first-order kinetics, while a biexponential model fitted degradation patterns for both SSBM and ESBM.
Agricultural Research Service, USDA, US Dairy Forage Research Center, Madison, WI 53706, USA. gbroderi@wisc.edu
Glen A
GA
Broderick
Michael L
ML
Murphy
Peter
P
Udén
D000596:Amino Acids / Q000378:metabolism; D000641:Ammonia / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001419:Bacteria / Q000187:drug effects / Q000378:metabolism; D002364:Caseins / Q000378:metabolism; D002417:Cattle; D002701:Chloramphenicol / Q000008:administration & dosage*; D004044:Dietary Proteins / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005285:Fermentation; D006834:Hydrazines / Q000008:administration & dosage*; D066298:In Vitro Techniques; D007700:Kinetics; D009584:Nitrogen / Q000378:metabolism; D010455:Peptides / Q000378:metabolism; D011500:Protein Synthesis Inhibitors / Q000008:administration & dosage*; D012417:Rumen / Q000187:drug effects* / Q000378:metabolism* / Q000382:microbiology; D013025:Glycine max / Q000378:metabolism
D000596:Amino Acids; D000900:Anti-Bacterial Agents; D002364:Caseins; D004044:Dietary Proteins; D006834:Hydrazines; D010455:Peptides; D011500:Protein Synthesis Inhibitors; C029424:hydrazine; D002701:Chloramphenicol; D000641:Ammonia; D009584:Nitrogen